Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ADMAADMA BIOLOGICS, INC.

Nasdaq · CIK 0001368514
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts446

Identity from submissions API

NameADMA BIOLOGICS, INC.
CIK0001368514
TickersADMA
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2836 Biological Products, (No Diagnostic Substances)
EIN562590442
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(201) 478-5552
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • R&R ACQUISITION VI, INC (2006-07-10T04:00:00.000Z → 2012-02-21T05:00:00.000Z)
Business address
C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17
RAMSEY
NJ
07446
NJ
Mailing address
C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17
RAMSEY
NJ
07446
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1004 filing rows loaded from submissions recent; extra archives: CIK0001368514-submissions-001.json (3 filings, 2006-07-10 to 2006-09-13).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 4 FORM 4 0001140361-26-044293 11475
2026-11-16 4 FORM 4 0001140361-26-044291 14159
2026-11-16 144 xsl144X01/primary_doc.xml 0001140361-26-044289 001-36728 261563742 33 4946
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128292 005-82025 261560821 34 15320
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000605 005-82025 261537763 34 8174
2026-11-05 4 FORM 4 0001140361-26-042166 14106
2026-11-05 144 xsl144X01/primary_doc.xml 0001140361-26-042164 001-36728 261529093 33 7152
2026-11-04 10-Q 10-Q 0001140361-26-041977 001-36728 261523760 34 8235543 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001140361-26-041959 001-36728 261522281 34 547387 1 1
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000402 005-82025 261251508 34 9531
2026-08-05 10-Q 10-Q 0001140361-26-031445 001-36728 261244839 34 8217618 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001140361-26-031423 001-36728 261243599 34 704481 1 1
2026-07-28 4 FORM 4 0001140361-26-029923 6954
2026-07-17 4 FORM 4 0001140361-26-028844 8555
2026-06-02 8-K 8-K 5.07 0001140361-26-023705 001-36728 261055901 34 166313 1 1
2026-05-28 4 FORM 4 0001140361-26-023127 8541
2026-05-14 4 FORM 4 0001140361-26-021150 8541
2026-05-12 4 FORM 4 0001140361-26-020855 8477
2026-05-06 10-Q 10-Q 0001140361-26-019336 001-36728 26949715 34 6529026 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001140361-26-019295 001-36728 26948455 34 464348 1 1
2026-05-04 8-K 8-K 8.01,9.01 0001140361-26-018667 001-36728 26934588 34 185237 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000078 005-82025 26916646 34 7489
2026-04-15 ARS ARS 0001140361-26-014803 001-36728 26864616 34 3227641
2026-04-15 DEFA14A DEFA14A 0001140361-26-014801 001-36728 26864565 34 1214978
2026-04-15 DEF 14A DEF 14A 0001140361-26-014799 001-36728 26864506 34 6808965 1 1
2026-04-03 4 FORM 4 0001140361-26-013206 6763
2026-03-27 8-K 8-K 7.01,9.01 0001140361-26-011569 001-36728 26801026 34 825638 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000527 005-82025 26797369 34 7248
2026-03-17 4 FORM 4 0001140361-26-009900 11754
2026-03-17 4 FROM 4 0001140361-26-009899 13729
2026-03-10 144 xsl144X01/primary_doc.xml 0001140361-26-008913 001-36728 26741392 33 6127
2026-03-10 4 FORM 4 0001140361-26-008905 29301
2026-03-10 4 FORM 4 0001140361-26-008904 9656
2026-03-09 144 xsl144X01/primary_doc.xml 0001140361-26-008523 001-36728 26736936 33 6218
2026-03-09 4 FORM 4 0001140361-26-008363 9205
2026-03-02 4 FORM 4 0001140361-26-007406 8553
2026-03-02 8-K 8-K 7.01,8.01,9.01 0001140361-26-007230 001-36728 26703428 34 182031 1 1
2026-02-26 3 FORM 3 0001140361-26-007008 13139
2026-02-25 10-K 10-K 0001140361-26-006815 001-36728 26680182 34 10974827 1 1
2026-02-25 8-K 8-K 2.02,5.02,9.01 0001140361-26-006781 001-36728 26678648 34 847283 1 1
2026-02-23 4 FORM 4 0001140361-26-006462 7005
2026-02-23 4 FORM 4 0001140361-26-006461 8553
2026-02-23 4 FORM 4 0001140361-26-006460 6356
2026-02-17 4 FORM 4 0001140361-26-005888 14012
2026-02-17 144 xsl144X01/primary_doc.xml 0001140361-26-005877 001-36728 26644964 33 7608
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000914208-26-000048 005-82025 26625637 34 7802
2026-02-11 4 FORM 4 0001140361-26-004892 11006
2026-02-11 4 FORM 4 0001140361-26-004891 9540
2026-02-11 4 FORM 4 0001140361-26-004890 11085
2026-02-11 4 FORM 4 0001140361-26-004889 7540
2026-02-11 4 FORM 4 0001140361-26-004888 7547
2026-02-11 4 FORM 4 0001140361-26-004887 7558
2026-02-11 4 FORM 4 0001140361-26-004886 8372
2026-02-11 4 FORM 4 0001140361-26-004885 9043
2026-01-12 8-K 8-K 2.02,7.01,9.01 0001140361-26-000906 001-36728 26524792 34 4140010 1 1
2025-12-16 4 FORM 4 0001140361-25-045737 13709
2025-11-21 4 FORM 4 0001140361-25-042997 13703
2025-11-05 10-Q 10-Q 0001140361-25-040578 001-36728 251455153 34 7289371 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001140361-25-040539 001-36728 251454083 34 532555 1 1
2025-10-24 4 FORM 4 0001140361-25-039331 13703
2025-10-24 144 xsl144X01/primary_doc.xml 0001140361-25-039330 001-36728 251417293 33 5600
2025-09-29 UPLOAD filename1.pdf 0000000000-25-010587 001-36728 39790
2025-09-26 CORRESP filename1.htm 0001140361-25-036301 28981
2025-09-16 4 FORM 4 0001140361-25-035159 13709
2025-09-16 UPLOAD filename1.pdf 0000000000-25-010019 001-36728 42394
2025-08-15 4 FORM 4 0001140361-25-031601 13709
2025-08-13 CORRESP filename1.htm 0001140361-25-030834 67113
2025-08-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-25-000431 005-82025 251200059 34 8152
2025-08-06 10-Q 10-Q 0001140361-25-029177 001-36728 251190669 34 7128449 1 1
2025-08-06 8-K 8-K 1.01,1.02,2.02,2.03,9.01 0001140361-25-029143 001-36728 251189658 34 2039457 1 1
2025-08-01 4 FORM 4 0001140361-25-028449 10127
2025-07-30 UPLOAD filename1.pdf 0000000000-25-008020 001-36728 45408
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000786 005-82025 251159065 34 6294
2025-07-28 4 FORM 4 0001140361-25-027642 6494
2025-07-28 4 FORM 4 0001140361-25-027641 6334
2025-07-23 CORRESP filename1.htm 0001140361-25-026973 32880
2025-07-16 4 FORM 4 0001140361-25-026099 13711
2025-07-16 UPLOAD filename1.pdf 0000000000-25-007484 001-36728 44426
2025-07-15 144 xsl144X01/primary_doc.xml 0001140361-25-025950 001-36728 251126061 33 6170
2025-06-30 4 FORM 4 0001140361-25-024252 6333
2025-06-18 4 FORM 4 0001140361-25-023017 13711
2025-06-16 4 FORM 4 0001140361-25-022713 43792
2025-06-12 144 xsl144X01/primary_doc.xml 0001140361-25-022350 001-36728 251044520 33 12943
2025-06-11 4 FORM 4 0001140361-25-022240 5705
2025-06-10 4 FORM 4 0001140361-25-022113 12278
2025-06-09 144 xsl144X01/primary_doc.xml 0001140361-25-021992 001-36728 251035761 33 3947
2025-06-04 8-K 8-K 5.07 0001140361-25-021440 001-36728 251024185 34 170153 1 1
2025-06-04 144 xsl144X01/primary_doc.xml 0001969223-25-000393 001-36728 251022653 33 4554
2025-05-23 4 FORM 4 0001140361-25-020376 15153
2025-05-21 144 xsl144X01/primary_doc.xml 0001140361-25-020078 001-36728 25974612 33 5156
2025-05-16 4 FORM 4 0001140361-25-019589 13710
2025-05-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-25-000236 005-82025 25937750 34 8151
2025-05-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000914208-25-000192 005-82025 25930584 34 13483
2025-05-07 10-Q 10-Q 0001140361-25-017747 001-36728 25922735 34 5858675 1 1
2025-05-07 8-K 8-K 2.02,8.01,9.01 0001140361-25-017704 001-36728 25921490 34 457181 1 1
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-001983 005-82025 25891754 34 11314
2025-04-28 8-K 8-K 8.01,9.01 0001140361-25-015881 001-36728 25875925 34 180316 1 1
2025-04-16 4 FORM 4 0001140361-25-014267 13710
2025-04-15 ARS ARS 0001140361-25-013974 001-36728 25840095 34 5497795
2025-04-15 DEFA14A DEFA14A 0001140361-25-013970 001-36728 25840041 34 292909
2025-04-15 DEF 14A DEF 14A 0001140361-25-013967 001-36728 25839953 34 6587431 1 1
2025-04-02 4 FORM 4 0001140361-25-011931 6495
2025-03-21 4 FORM 4 0001140361-25-009928 13702
2025-03-19 144 xsl144X01/primary_doc.xml 0001140361-25-009530 001-36728 25754304 33 4457
2025-03-18 10-K 10-K 0001140361-25-009257 001-36728 25748408 34 14140291 1 1
2025-03-10 4 FORM 4 0001140361-25-007924 11081
2025-03-10 4 FORM 4 0001140361-25-007923 9621
2025-03-03 NT 10-K NT 10-K 0001140361-25-006796 001-36728 25699550 34 133111
2025-03-03 8-K 8-K 2.02,9.01 0001140361-25-006745 001-36728 25697826 34 546279 1 1
2025-02-27 4 FORM 4 0001140361-25-006386 11187
2025-02-27 4 FORM 4 0001140361-25-006385 6416
2025-02-27 4 FORM 4 0001140361-25-006384 6331
2025-02-21 4 FORM 4 0001140361-25-005540 7479
2025-02-21 4 FORM 4 0001140361-25-005542 8338
2025-02-21 4 FORM 4 0001140361-25-005539 7261
2025-02-21 4 FORM 4 0001140361-25-005541 8910
2025-02-21 4 FORM 4 0001140361-25-005538 10977
2025-02-21 4 FORM 4 0001140361-25-005537 14783
2025-02-21 4 FORM 4 0001140361-25-005536 8760
2025-02-21 4 FORM 4 0001140361-25-005535 9154
2025-02-21 4 FORM 4 0001140361-25-005534 10903
2025-02-21 8-K 8-K 5.02,9.01 0001140361-25-005489 001-36728 25653320 34 183024 1 1
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000914208-25-000062 005-82025 25600866 34 7858
2025-02-03 4 FORM 4 0001140361-25-002926 10100
2025-01-13 8-K 8-K 7.01,9.01 0001140361-25-000871 001-36728 25524787 34 5590924 1 1
2025-01-13 8-K 8-K 2.02,9.01 0001140361-25-000870 001-36728 25524762 34 204188 1 1
2025-01-03 4 FORM 4 0001140361-25-000271 6465
2025-01-03 4 FORM 4 0001140361-25-000270 8107
2025-01-02 4 FORM 4 0001140361-25-000079 5326
2025-01-02 3 FORM 3 0001140361-25-000078 10837
2025-01-02 8-K 8-K 5.02,9.01 0001140361-25-000073 001-36728 25502042 34 165125 1 1
2024-12-20 8-K 8-K 8.01,9.01 0001140361-24-050002 001-36728 241565091 34 175958 1 1
2024-12-02 4 FORM 4 0001140361-24-048224 16452
2024-11-22 4 FORM 4 0001140361-24-047702 6006
2024-11-22 4 xslF345X05/form4.xml 0001140361-24-047701 9063
2024-11-22 144 xsl144X01/primary_doc.xml 0001140361-24-047700 001-36728 241491691 33 5027
2024-11-22 144 xsl144X01/primary_doc.xml 0001140361-24-047699 001-36728 241491690 33 3948
2024-11-21 8-K 8-K 5.02,9.01 0001140361-24-047487 001-36728 241484871 34 161775 1 1
2024-11-12 SC 13G/A UnitedStates_13G__ADMABiolog.txt 0000932471-24-000904 005-82025 241446593 34 6687
2024-11-08 SC 13G SEC SCHEDULE 13G 0000914208-24-000495 005-82025 241438219 34 24080
2024-11-07 10-Q 10-Q 0001140361-24-045693 001-36728 241436890 34 9284422 1 1
2024-11-07 8-K 8-K 2.02,9.01 0001140361-24-045657 001-36728 241435729 34 483698 1 1
2024-11-04 SC 13G UnitedStates_13G__ADMABiolog.txt 0000932471-24-000272 005-82025 241421384 34 5747
2024-10-31 8-K 8-K 4.01,9.01 0001140361-24-044808 001-36728 241416281 34 165734 1 1
2024-10-17 SC 13G ADMA_Biologics_Inc.htm 0000093751-24-000773 005-82025 241376125 34 56115
2024-10-10 8-K 8-K 7.01,9.01 0001140361-24-043250 001-36728 241363959 34 162507 1 1
2024-10-09 8-K 8-K 4.01,9.01 0001140361-24-043222 001-36728 241363383 34 177480 1 1
2024-10-07 SC 13G/A us0008991046_100724.txt 0002012383-24-000123 005-82025 241357931 34 13860
2024-10-02 4 FORM 4 0001140361-24-042642 6928
2024-10-02 4 FORM 4 0001140361-24-042641 8650
2024-09-23 SC 13G ADMA_SC13G_Sept2024.htm 0001273087-24-000090 005-82025 241316530 34 82236
2024-09-11 4 FORM 4 0001140361-24-040872 18871
2024-09-09 144 xsl144X01/primary_doc.xml 0001140361-24-040640 001-36728 241288591 33 3923
2024-08-30 4 FORM 4 0001140361-24-039822 21279
2024-08-30 4 FORM 4 0001140361-24-039821 26850
2024-08-30 144 xsl144X01/primary_doc.xml 0001140361-24-039819 001-36728 241271641 33 3970
2024-08-29 144 xsl144X01/primary_doc.xml 0001140361-24-039381 001-36728 241265638 33 3929
2024-08-27 4 FORM 4 0001140361-24-038772 36634
2024-08-27 4 FORM 4 0001140361-24-038770 13522
2024-08-26 144 xsl144X01/primary_doc.xml 0001140361-24-038629 001-36728 241243052 33 4502
2024-08-14 8-K 8-K 8.01,9.01 0001140361-24-037184 001-36728 241204517 34 177490 1 1
2024-08-08 10-Q 10-Q 0001140361-24-036432 001-36728 241189433 34 9010656 1 1
2024-08-08 8-K 8-K 2.02,9.01 0001140361-24-036399 001-36728 241188383 34 508619 1 1
2024-07-26 4 FORM 4 0001140361-24-034472 6929
2024-07-26 4 FORM 4 0001140361-24-034471 8351
2024-07-26 3 FORM 3 0001140361-24-034468 16281
2024-07-26 8-K 8-K 5.02,9.01 0001140361-24-034440 001-36728 241148057 34 296858 1 1
2024-07-02 4 FORM 4 0001140361-24-032247 6929
2024-07-02 4 FORM 4 0001140361-24-032245 8627
2024-06-28 8-K 8-K 5.03,9.01 0001140361-24-031778 001-36728 241086262 34 413257 1 1
2024-06-14 4 FORM 4 0001140361-24-030232 12338
2024-06-14 144 xsl144X01/primary_doc.xml 0001140361-24-030218 001-36728 241045967 33 4099
2024-06-04 8-K 8-K 5.07,9.01 0001140361-24-028800 001-36728 241017943 34 174483 1 1
2024-05-17 8-K 8-K 7.01,9.01 0001140361-24-026601 001-36728 24957856 34 5279164 1 1
2024-05-09 10-Q 10-Q 0001140361-24-025226 001-36728 24931710 34 7432267 1 1
2024-05-09 8-K 8-K 2.02,9.01 0001140361-24-025173 001-36728 24930511 34 442019 1 1
2024-04-15 ARS ARS 0001140361-24-019876 001-36728 24845154 34 3916910
2024-04-15 DEFA14A DEFA14A 0001140361-24-019869 001-36728 24845109 34 2061702
2024-04-15 DEF 14A DEF 14A 0001140361-24-019868 001-36728 24845041 34 2440458
2024-04-02 4 FORM 4 0001140361-24-017377 9425
2024-04-02 4 FORM 4 0001140361-24-017376 17383
2024-04-02 3 FORM 3 0001140361-24-017372 33012
2024-04-02 8-K 8-K 5.02,9.01 0001140361-24-017331 001-36728 24815557 34 299008 1 1
2024-03-19 4 FORM 4 0001140361-24-014226 8744
2024-03-15 4 FORM 4 0001140361-24-013634 10701
2024-03-13 144 xsl144X01/primary_doc.xml 0001961863-24-000106 001-36728 24746594 33 4517
2024-03-11 8-K 8-K 8.01,9.01 0001140361-24-012605 001-36728 24737976 34 189780 1 1
2024-03-11 SC 13G/A c108460_sc13ga.htm 0000930413-24-000915 005-82025 24737219 34 70870
2024-03-11 SC 13G/A c108459_sc13ga.htm 0000930413-24-000914 005-82025 24737206 34 70880
2024-03-11 SC 13G/A c108458_sc13ga.htm 0000930413-24-000913 005-82025 24737193 34 70759
2024-03-08 4 FORM 4 0001140361-24-012446 7568
2024-03-08 4 FORM 4 0001140361-24-012445 9745
2024-03-05 8-K 8-K 7.01,9.01 0001140361-24-011399 001-36728 24720258 34 5311471 1 1
2024-03-04 4 xslF345X05/form4.xml 0001140361-24-011194 8190
2024-03-04 4 FORM 4 0001140361-24-011193 6095
2024-02-28 4 FORM 4 0001140361-24-010242 7233
2024-02-28 4 FORM 4 0001140361-24-010243 11006
2024-02-28 4 FORM 4 0001140361-24-010241 10856
2024-02-28 4 FORM 4 0001140361-24-010239 7386
2024-02-28 4 FORM 4 0001140361-24-010240 8219
2024-02-28 4 FORM 4 0001140361-24-010238 7346
2024-02-28 4 FORM 4 0001140361-24-010237 8750
2024-02-28 10-K 10-K 0001140361-24-010147 001-36728 24696575 34 10923493 1 1
2024-02-28 8-K 8-K 5.02,8.01,9.01 0001140361-24-010100 001-36728 24695740 34 301538 1 1
2024-02-28 8-K 8-K 2.02,9.01 0001140361-24-010088 001-36728 24695569 34 516576 1 1
2024-02-27 4 FORM 4 0001140361-24-009843 6346
2024-02-27 4 FORM 4 0001140361-24-009842 8242
2024-02-21 8-K 8-K 8.01,9.01 0001140361-24-008680 001-36728 24656425 34 185565 1 1
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036449 005-82025 24639749 34 65076
2024-02-14 SC 13G c108118_sc13g.htm 0000930413-24-000591 005-82025 24634640 34 65671
2024-02-14 SC 13G c108115_sc13g.htm 0000930413-24-000589 005-82025 24634611 34 65782
2024-02-14 SC 13G c108111_sc13g.htm 0000930413-24-000586 005-82025 24634515 34 65792
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-020178 005-82025 24627264 34 13149
2024-01-26 SC 13G/A us0008991046_012624.txt 0001086364-24-004324 005-82025 24565823 34 13709
2024-01-08 8-K 8-K 7.01,9.01 0001140361-24-001198 001-36728 24518390 34 5276766 1 1
2024-01-08 8-K 8-K 2.02,9.01 0001140361-24-001194 001-36728 24518338 34 214571 1 1
2024-01-05 4 FORM 4 0001140361-24-001139 6594
2024-01-05 4 xslF345X05/form4.xml 0001140361-24-001138 8475
2023-12-18 8-K 8-K 1.01,1.02,2.03,8.01,9.01 0001140361-23-058160 001-36728 231494166 34 1998437 1 1
2023-12-12 8-K 8-K 8.01,9.01 0001140361-23-057341 001-36728 231481598 34 196828 1 1
2023-11-16 8-K 8-K 8.01,9.01 0001140361-23-053665 001-36728 231415045 34 188519 1 1
2023-11-08 10-Q 10-Q 0001140361-23-052109 001-36728 231389054 34 8864853 1 1
2023-11-08 8-K 8-K 2.02,9.01 0001140361-23-052102 001-36728 231388559 34 528570 1 1
2023-10-03 4 xslF345X05/form4.xml 0001140361-23-046743 8394
2023-10-03 4 xslF345X05/form4.xml 0001140361-23-046742 6493
2023-10-02 3 xslF345X02/form3.xml 0001140361-23-046339 13360
2023-10-02 8-K 8-K 5.02,9.01 0001140361-23-046335 001-36728 231300317 34 165766 1 1
2023-08-30 4 xslF345X05/form4.xml 0001140361-23-041848 8475
2023-08-24 4 xslF345X05/form4.xml 0001140361-23-041191 4762
2023-08-23 4 xslF345X05/form4.xml 0001140361-23-041054 5907
2023-08-22 144 xsl144X01/primary_doc.xml 0001968582-23-000431 001-36728 231194463 33 5554
2023-08-18 4 xslF345X05/form4.xml 0001140361-23-040583 8638
2023-08-18 144/A xsl144X01/primary_doc.xml 0001140361-23-040447 001-36728 231184885 33 10006
2023-08-17 4 xslF345X05/form4.xml 0001140361-23-040322 33756
2023-08-17 4 xslF345X05/form4.xml 0001140361-23-040321 32172
2023-08-14 144 xsl144X01/primary_doc.xml 0001140361-23-039795 001-36728 231172979 33 12116
2023-08-14 144 xsl144X01/primary_doc.xml 0001140361-23-039793 001-36728 231172970 33 8338
2023-08-09 10-Q 10-Q 0001140361-23-038843 001-36728 231156166 34 8576216 1 1
2023-08-09 8-K 8-K 2.02,9.01 0001140361-23-038803 001-36728 231155366 34 419348 1 1
2023-07-19 8-K 8-K 8.01,9.01 0001140361-23-035123 001-36728 231095574 34 193758 1 1
2023-07-05 4 xslF345X04/form4.xml 0001140361-23-033191 6493
2023-07-05 4 xslF345X04/form4.xml 0001140361-23-033190 8394
2023-06-06 8-K 8-K 5.07,9.01 0001140361-23-028551 001-36728 23996481 34 170722 1 1
2023-05-22 DEFA14A DEFA14A 0001140361-23-025874 001-36728 23942440 34 11731
2023-05-22 8-K 8-K 8.01,9.01 0001140361-23-025873 001-36728 23942434 34 164809 1 1
2023-05-10 10-Q 10-Q 0001140361-23-023920 001-36728 23907484 34 7444836 1 1
2023-05-10 8-K 8-K 2.02,9.01 0001140361-23-023899 001-36728 23906567 34 380377 1 1
2023-05-02 8-K 8-K 1.01,3.02,8.01,9.01 0001140361-23-022312 001-36728 23876850 34 1453364 1 1
2023-04-13 ARS ARS 0001140361-23-018241 001-36728 23818783 34 3513681
2023-04-13 DEFA14A DEFA14A 0001140361-23-018239 001-36728 23818761 34 3805123
2023-04-13 DEF 14A DEF 14A 0001140361-23-018237 001-36728 23818726 34 2338060
2023-04-04 4 xslF345X04/form4.xml 0001140361-23-016460 6493
2023-04-04 4 xslF345X04/form4.xml 0001140361-23-016458 8393
2023-03-23 10-K 10-K 0001140361-23-013467 001-36728 23757089 34 9012218 1 1
2023-03-23 8-K 8-K 2.02,9.01 0001140361-23-013402 001-36728 23756388 34 418214 1 1
2023-03-10 8-K 8-K 5.02,9.01 0001140361-23-011200 001-36728 23724405 34 185017 1 1
2023-03-08 4 xslF345X03/form4.xml 0001140361-23-010774 16254
2023-03-08 4 xslF345X03/form4.xml 0001140361-23-010773 14305
2023-03-08 4 xslF345X03/form4.xml 0001140361-23-010772 10724
2023-03-08 4 xslF345X03/form4.xml 0001140361-23-010771 8618
2023-03-08 4 xslF345X03/form4.xml 0001140361-23-010770 8087
2023-03-08 4 xslF345X03/form4.xml 0001140361-23-010769 7569
2023-03-08 4 xslF345X03/form4.xml 0001140361-23-010768 7254
2023-03-08 4 xslF345X03/form4.xml 0001140361-23-010767 8188
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-038718 005-82025 23627228 34 64760
2023-02-14 SC 13G/A c105525_sc13ga.htm 0000930413-23-000387 005-82025 23623035 34 80026
2023-02-14 SC 13G/A c105524_sc13ga.htm 0000930413-23-000386 005-82025 23623021 34 80050
2023-02-14 SC 13G/A c105523_sc13ga.htm 0000930413-23-000385 005-82025 23623016 34 80075
2023-02-13 SC 13G/A adma13ga.htm 0000935836-23-000131 005-82025 23615618 34 60677
2023-02-08 8-K 8-K 8.01,9.01 0001140361-23-005120 001-36728 23597073 34 195076 1 1
2023-02-03 SC 13G us0008991046_020323.txt 0001306550-23-007061 005-82025 23584707 34 13368
2023-01-17 8-K 8-K 2.02,9.01 0001140361-23-001727 001-36728 23530355 34 196122 1 1
2023-01-06 4 xslF345X03/form4.xml 0001140361-23-000873 8071
2023-01-06 4 xslF345X03/form4.xml 0001140361-23-000872 6198
2022-12-09 SC 13D/A ADMA BIOLOGICS, INC. 0000902664-22-005090 005-82025 221455462 34 52751
2022-12-09 4 xslF345X03/form4.xml 0001140361-22-045112 6461
2022-12-09 4 xslF345X03/form4.xml 0001140361-22-045111 9258
2022-12-09 8-K FORM 8-K 8.01,9.01 0001140361-22-045106 001-36728 221455184 34 207488 1 1
2022-12-07 424B5 424B5 0001140361-22-044743 333-256643 221450625 33 889125
2022-12-07 8-K FORM 8-K 1.01,8.01,9.01 0001140361-22-044667 001-36728 221449234 34 429157 1 1
2022-12-06 8-K FORM 8-K 2.02,8.01,9.01 0001140361-22-044592 001-36728 221448028 34 211002 1 1
2022-12-06 424B5 424B5 0001140361-22-044591 333-256643 221448002 33 890288
2022-11-09 10-Q 10-Q 0001140361-22-040738 001-36728 221373698 34 8760075 1 1
2022-11-09 8-K 8-K 2.02,9.01 0001140361-22-040700 001-36728 221372843 34 426356 1 1
2022-10-31 8-K 8-K 8.01,9.01 0001140361-22-039119 001-36728 221346407 34 191366 1 1
2022-10-04 4 xslF345X03/form4.xml 0001140361-22-036164 8124
2022-10-04 4 xslF345X03/form4.xml 0001140361-22-036163 6252
2022-08-10 10-Q 10-Q 0001140361-22-029116 001-36728 221152850 34 8417830 1 1
2022-08-10 8-K 8-K 2.02,9.01 0001140361-22-029079 001-36728 221152006 34 413502 1 1
2022-07-22 S-8 POS S-8 POS 0001140361-22-026728 333-263345 221100291 33 94467
2022-07-22 S-8 POS S-8 POS 0001140361-22-026727 333-254770 221100289 33 94467
2022-07-22 S-8 POS S-8 POS 0001140361-22-026726 333-237658 221100287 33 94467
2022-07-22 S-8 POS S-8 POS 0001140361-22-026725 333-229921 221100285 33 94467
2022-07-22 S-8 POS S-8 POS 0001140361-22-026724 333-224492 221100283 33 94467
2022-07-22 S-8 POS S-8 POS 0001140361-22-026723 333-220058 221100281 33 94467
2022-07-22 S-8 POS S-8 POS 0001140361-22-026722 333-204590 221100279 33 94467
2022-07-22 S-8 S-8 0001140361-22-026720 333-266291 221100259 33 146337
2022-06-28 SC 13G ADMA_SC13G.htm 0001273087-22-000084 005-82025 221050651 34 82087
2022-06-27 8-K 8-K 8.01,9.01 0001140361-22-024139 001-36728 221044989 34 190173 1 1
2022-06-21 8-K 8-K 5.02,5.07,9.01 0001140361-22-023666 001-36728 221028836 34 331205 1 1
2022-06-16 15-12B 15-12B 0001140361-22-023154 001-36728 221019246 34 9492
2022-06-13 8-K 8-K 8.01 0001140361-22-022769 001-36728 221012041 34 198479 1 1
2022-05-13 4 FORM 4 0001140361-22-019216 6889
2022-05-13 4 FORM 4 0001140361-22-019215 8760
2022-05-11 10-Q 10-Q 0001140361-22-018668 001-36728 22914429 34 7449414 1 1
2022-05-11 8-K 8-K 2.02,9.01 0001140361-22-018655 001-36728 22913918 34 419715 1 1
2022-04-28 DEFA14A DEFA14A 0001140361-22-016598 001-36728 22867422 34 5320704
2022-04-28 DEF 14A DEF 14A 0001140361-22-016578 001-36728 22867302 34 1977285
2022-03-25 4 FORM 4 0001140361-22-011251 7165
2022-03-25 4 FORM 4 0001140361-22-011249 9275
2022-03-25 8-K 8-K 8.01,9.01 0001140361-22-011213 001-36728 22771820 34 229919 1 1
2022-03-24 10-K 10-K 0001140361-22-011030 001-36728 22767503 34 10388957 1 1
2022-03-24 8-K 8-K 2.02,9.01 0001140361-22-011028 001-36728 22767429 34 462143 1 1
2022-03-09 4 FORM 4 0001140361-22-008677 7159
2022-03-09 4 FORM 4 0001140361-22-008676 8449
2022-03-09 4 FORM 4 0001140361-22-008675 7992
2022-03-09 4 FORM 4 0001140361-22-008674 8092
2022-03-09 4 FORM 4 0001140361-22-008673 10068
2022-03-09 4 FORM 4 0001140361-22-008672 7473
2022-03-09 4 FORM 4 0001140361-22-008671 11941
2022-03-09 4 FORM 4 0001140361-22-008670 10629
2022-03-09 8-K 8-K 5.02,9.01 0001140361-22-008654 001-36728 22726300 34 228822 1 1
2022-03-07 S-8 S-8 0001140361-22-008177 333-263345 22718684 33 79166
2022-03-07 8-K 8-K 8.01,9.01 0001140361-22-008174 001-36728 22718425 34 236346 1 1
2022-02-15 SC 13G/A SC 13G/A 0001193125-22-042591 005-82025 22636638 34 64713
2022-02-14 SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-22-001032 005-82025 22629121 34 58447
2022-02-14 SC 13G/A adma13ga.htm 0000935836-22-000120 005-82025 22625517 34 60778
2022-02-11 SC 13G c103002_sc13g.htm 0000930413-22-000208 005-82025 22619572 34 37198
2022-02-04 SC 13D ADMA BIOLOGICS, INC. 0000902664-22-001112 005-82025 22591100 34 71854
2022-01-19 8-K 8-K 2.02,9.01 0001140361-22-001914 001-36728 22536857 34 249870 1 1
2022-01-18 8-K 8-K 8.01,9.01 0001140361-22-001782 001-36728 22533702 34 230813 1 1
2021-12-30 SC 13G adma13g2.htm 0000935836-21-000703 005-82025 211531627 34 60367
2021-12-21 8-A12B 8-A12B 0001140361-21-042614 001-36728 211510008 34 48272
2021-12-21 8-K 8-K 1.01,3.03,5.03,8.01,9.01 0001140361-21-042611 001-36728 211509983 34 745811 1 1
2021-12-21 15-12B 15-12B 0001140361-21-042609 001-36728 211509962 34 10660
2021-12-09 8-K 8-K 8.01,9.01 0001140361-21-040956 001-36728 211480335 34 227499 1 1
2021-12-01 8-K 8-K 7.01,9.01 0001140361-21-040002 001-36728 211463796 34 5853332 1 1
2021-11-16 8-K 8-K 8.01,9.01 0001140361-21-038017 001-36728 211414243 34 235353 1 1
2021-11-10 10-Q 10-Q 0001140361-21-037463 001-36728 211397828 34 8648733 1 1
2021-11-10 8-K 8-K 2.02,9.01 0001140361-21-037447 001-36728 211397134 34 430959 1 1
2021-10-27 SC 13G/A SC 13G/A 0001193125-21-308803 005-82025 211350973 34 65726
2021-10-26 4 FORM 4 0001140361-21-035382 4434
2021-10-26 4 FORM 4 0001140361-21-035381 7904
2021-10-26 4 FORM 4 0001140361-21-035380 7280
2021-10-26 4 FORM 4 0001140361-21-035379 9988
2021-10-25 8-K 8-K 8.01,9.01 0001140361-21-035296 001-36728 211344479 34 253736 1 1
2021-10-21 424B5 424B5 0001140361-21-035106 333-256643 211337406 33 394865
2021-10-21 8-K 8-K 1.01,8.01,9.01 0001140361-21-035103 001-36728 211337315 34 507776 1 1
2021-10-20 424B5 424B5 0001140361-21-035011 333-256643 211334893 33 396811
2021-10-20 8-K 8-K 2.02,8.01,9.01 0001140361-21-034997 001-36728 211334470 34 246690 1 1
2021-10-18 4 FORM 4 0001140361-21-034767 5350
2021-10-18 3 FORM 3 0001140361-21-034764 11196
2021-10-18 8-K 8-K 5.02,9.01 0001140361-21-034761 001-36728 211328996 34 234025 1 1
2021-10-01 4 FORM 4 0001140361-21-033355 8880
2021-10-01 4 FORM 4 0001140361-21-033354 10750
2021-10-01 8-K 8-K 5.02,9.01 0001140361-21-033302 001-36728 211299832 34 320388 1 1
2021-09-30 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-009017 13133
2021-09-29 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-009000 11102
2021-09-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-008979 9123
2021-09-03 8-K FORM 8-K 1.01,9.01 0001140361-21-030391 001-36728 211237282 34 630153 1 1
2021-09-03 424B5 424B5 0001140361-21-030388 333-256643 211237248 33 275298
2021-08-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-007800 13081
2021-08-17 8-K 8-K 1.02 0001140361-21-028679 001-36728 211183371 34 203916 1 1
2021-08-16 8-K 8-K 8.01,9.01 0001140361-21-028496 001-36728 211179798 34 237087 1 1
2021-08-12 8-K 8-K 8.01,9.01 0001140361-21-027961 001-36728 211164915 34 279713 1 1
2021-08-12 8-K 8-K 2.02,9.01 0001140361-21-027959 001-36728 211164880 34 410532 1 1
2021-08-11 10-Q 10-Q 0001140361-21-027950 001-36728 211164451 34 8527112 1 1
2021-08-03 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-08-03 16:00:00 9999999995-21-003034 333-256643 211142169 33 1851
2021-08-03 S-3/A S-3/A 0001140361-21-026544 333-256643 211138201 33 102815
2021-07-30 CORRESP filename1.htm 0001140361-21-026182 7189
2021-07-27 8-K 8-K 8.01 0001140361-21-025680 001-36728 211115886 34 203230 1 1
2021-07-20 8-K 8-K 8.01,9.01 0001140361-21-024961 001-36728 211101488 34 233615 1 1
2021-06-14 8-K e620714_8k-adma.htm 5.02 0001193805-21-000863 001-36728 211015291 34 242738 1 1
2021-06-03 UPLOAD filename1.pdf 0000000000-21-006916 40312
2021-05-28 8-K e620652_8k-adma.htm 1.01,9.01 0001193805-21-000751 001-36728 21981138 34 539573 1 1
2021-05-28 S-3 e620636_s3-adma.htm 0001193805-21-000750 333-256643 21981123 33 1142107
2021-05-28 8-K e620651_8k-adma.htm 5.07,9.01 0001193805-21-000749 001-36728 21981087 34 261362 1 1
2021-05-12 10-Q adma_10q.htm 0001193805-21-000657 001-36728 21916091 34 4494167 1 1
2021-05-12 8-K e620590_8k-adma.htm 2.02,9.01 0001193805-21-000653 001-36728 21915542 34 357600 1 1
2021-04-28 8-K e620523_8k-adma.htm 8.01,9.01 0001193805-21-000549 001-36728 21861918 34 266880 1 1
2021-04-12 SC 13G/A us0008991046_040921.txt 0000834237-21-008112 005-82025 21818786 34 12437
2021-04-08 DEFA14A DEFA14A 0001140361-21-012044 001-36728 21813161 34 362042
2021-04-07 DEF 14A DEF 14A 0001140361-21-012041 001-36728 21813135 34 1772807
2021-03-26 S-8 e620410_s8-adma.htm 0001193805-21-000422 333-254770 21777682 33 65224
2021-03-26 PRE 14A DEF 14A 0001140361-21-010228 001-36728 21777462 34 1763837
2021-03-25 10-K adma_10k.htm 0001193805-21-000411 001-36728 21773524 34 6357920 1 1
2021-03-25 8-K e620413_8k-adma.htm 2.02,9.01 0001193805-21-000409 001-36728 21772761 34 380467 1 1
2021-03-02 8-K e620325_8k-adma.htm 5.02,9.01 0001193805-21-000299 001-36728 21700869 34 260676 1 1
2021-03-01 4 xslF345X03/e620333_4-demski.xml 0001193805-21-000298 5372
2021-03-01 4 xslF345X03/e620332_4-guiheen.xml 0001193805-21-000297 5369
2021-03-01 4 xslF345X03/e620331_4-fong.xml 0001193805-21-000296 5354
2021-03-01 4 xslF345X03/e620330_4-jgrossman.xml 0001193805-21-000295 5373
2021-03-01 4 xslF345X03/e620329_4-elms.xml 0001193805-21-000294 5343
2021-03-01 4 xslF345X03/e620328_4-agrossman.xml 0001193805-21-000293 10065
2021-03-01 4 xslF345X03/e620327_4-mond.xml 0001193805-21-000292 8272
2021-03-01 4 xslF345X03/e620326_4-lenz.xml 0001193805-21-000291 8230
2021-02-16 SC 13G/A SC 13G/A 0001193125-21-044726 005-82025 21637276 34 66928
2021-02-16 SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-000910 005-82025 21636111 34 58307
2021-02-03 8-K e620246_8k-adma.htm 1.01,8.01,9.01 0001193805-21-000126 001-36728 21587035 34 308378 1 1
2021-02-03 424B5 e620243_424b5-adma.htm 0001193805-21-000125 333-234107 21587023 33 260051

Latest XBRL company facts

One latest value per concept from companyfacts (446 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 221.85M 2026-10-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
dei EntityPublicFloat Entity Public Float USD 4.23B 2025-06-30 2025 FY 10-K 2026-02-25 0001140361-26-006815
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.36M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001140361-26-014799
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.87M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001140361-26-014799
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 125.85 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001140361-26-014799
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 13.62M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001140361-26-014799
ecd PeoTotalCompAmt PeoTotalCompAmt USD 10.24M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001140361-26-014799
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 106.36 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001140361-26-014799
srt StockRepurchaseProgramAuthorizedAmount1 StockRepurchaseProgramAuthorizedAmount1 USD 500.00M 2025-05-31 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AccountsPayableAndAccruedLiabilitiesFairValueDisclosure Accounts Payable and Accrued Liabilities, Fair Value Disclosure USD 290,000 2019-03-31 2019 Q1 10-Q 2019-05-08 0001193805-19-000455
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 35.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AccountsPayableRelatedPartiesCurrentAndNoncurrent Accounts Payable, Related Parties USD 296,362 2019-03-31 2019 Q1 10-Q 2019-05-08 0001193805-19-000455
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 169.22M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AccountsReceivableRelatedParties Accounts Receivable, Related Parties USD 0 2019-03-31 2019 Q1 10-Q 2019-05-08 0001193805-19-000455
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 4.96M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 2.83M 2024-06-30 2024 Q2 10-Q 2024-08-08 0001140361-24-036432
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 54.22M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.37M 2020-12-31 2020 FY 10-K 2021-03-25 0001193805-21-000411
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 8.59M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap AccruedLiabilitiesFairValueDisclosure Accrued Liabilities, Fair Value Disclosure USD 24,049 2019-03-31 2019 Q1 10-Q 2019-05-08 0001193805-19-000455
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 16.85M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 2.79M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 43.45M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 680.84M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AdjustmentForAmortization Amortization USD 200,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 556,418 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 879,907 2019-04-01 2019-06-30 2020 Q2 10-Q 2020-08-05 0001193805-20-000960
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 774,784 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 6.20M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 5.59M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 589,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001193805-14-000641
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 170,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AssetAcquisitionConsiderationTransferred AssetAcquisitionConsiderationTransferred USD 12.60M 2025-07-01 2025-07-31 2025 Q3 10-Q 2025-11-05 0001140361-25-040578
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap Assets Assets USD 732.49M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AssetsCurrent Assets, Current USD 575.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap AssetsNet Net Assets USD 191.54M 2020-06-30 2020 Q2 10-Q 2020-08-05 0001193805-20-000960
us-gaap AssetsNoncurrent Assets, Noncurrent USD 29,563 2017-03-31 2017 Q1 10-Q 2017-05-12 0001193805-17-000815
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 6.53M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap BasicEarningsPerShareProForma Basic Earnings Per Share, Pro Forma USD/shares -1.17 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount Business Acquisition, Goodwill, Expected Tax Deductible Amount USD 1.08M 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -52.93M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 379.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 3.90M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net USD 12.60M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 59.79M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable USD 47.17M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationConsiderationTransferredOther1 Business Combination, Consideration Transferred, Other USD 12.62M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 0 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 12.50M 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities USD 845,389 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other USD 795,553 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets USD 907,421 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill USD 1.08M 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 4.10M 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory USD 8.20M 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land USD 20.00M 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 374,317 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 8.21M 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross USD 188,277 2016-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 275,988 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 2.86M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap Cash Cash USD 101.24M 2020-03-31 2020 Q1 10-Q 2020-05-06 0001193805-20-000562
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 124.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 6.04M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 124.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 36.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 45.30M 2024-03-31 2024 Q1 10-Q 2024-05-09 0001140361-24-025226
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 1.99 2023-03-31 2023 Q1 10-Q 2023-05-10 0001140361-23-023920
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 966,554 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 38.10M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001140361-25-040578
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001193805-21-000411
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 55.72M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 241.25M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 222.79M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 9.87M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap CommonStockValue Common Stock, Value, Issued USD 24,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 143,000 2025-06-30 2025 Q2 10-Q 2025-08-06 0001140361-25-029177
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-15 0001193805-12-000925
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 200,000 2012-09-30 2012 Q3 10-Q 2012-11-13 0001193805-12-001795
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 12.24M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193805-18-000666
us-gaap CostOfRevenue Cost of Revenue USD 113.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 21.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 24.71M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 2.78M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 1.36 2019-04-11 2019-05-03 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD -8.15M 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 197.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 81.21M 2020-03-31 2020 Q1 10-Q 2020-05-06 0001193805-20-000562
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001193805-16-004233
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.137 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 1.60M 2025-06-30 2025 Q2 10-Q 2025-08-06 0001140361-25-029177
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD -30,140 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-09 0001193805-15-000352
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 3,554 2016-03-31 2016 Q1 10-Q 2016-05-13 0001193805-16-003247
us-gaap DeferredCreditsAndOtherLiabilitiesNoncurrent Deferred Credits and Other Liabilities, Noncurrent USD 90,476 2017-03-31 2017 Q1 10-Q 2017-05-12 0001193805-17-000815
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 9.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Net USD 363,403 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 70.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 2.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 9.11M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredRevenue Deferred Revenue USD 1.62M 2013-06-30 2013 Q2 10-Q 2013-08-12 0001193805-13-001413
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 142,834 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 1.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 3.33M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 434,000 2023-12-31 2023 FY 10-K 2024-02-28 0001140361-24-010147
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 93.98M 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 3.98M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 73.26M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 82.37M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 64.43M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 58.90M 2014-12-31 2014 FY 10-K 2015-03-09 0001193805-15-000352
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 778,000 2023-12-31 2023 FY 10-K 2024-02-28 0001140361-24-010147
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 3.00M 2014-12-31 2014 FY 10-K 2015-03-09 0001193805-15-000352
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 140,000 2023-12-31 2023 FY 10-K 2024-02-28 0001140361-24-010147
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.92M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 4.32M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 0 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 791,000 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 2.22M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap Depreciation Depreciation USD 2.20M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 5.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 5.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2015-12-31 2015 FY 10-K 2016-03-23 0001193805-16-002889
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 153,557 2011-12-31 2012 Q2 10-Q 2012-02-01 0001144204-12-005166
us-gaap DilutedEarningsPerShareProForma Diluted Earnings Per Share Pro Forma USD/shares -1.17 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Current USD 59,000 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current USD 4.23M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.16 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.57 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.196 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.231 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -8.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.043 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.021 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 5.70M 2020-03-31 2020 Q1 10-Q 2020-05-06 0001193805-20-000562
us-gaap EquityIssuanceDollarAmountPerShare Equity Issuance, Amount Per Share (Deprecated 2012-01-31) USD 0 2006-06-30 2012 Q2 10-Q 2012-02-01 0001144204-12-005166
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 74,356 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-09 0001193805-15-000352
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 5.11M 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months USD 140,000 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 715,352 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 25,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0001140361-24-045693
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four USD 50,000 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three USD 130,000 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two USD 140,000 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 298,065 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 715,352 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 715,352 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 536,514 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 5.57M 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 460,000 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap FiniteLivedIntangibleAssetsPeriodIncreaseDecrease Finite-Lived Intangible Assets, Period Increase (Decrease) USD 400,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001140361-24-045693
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 8.00M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap GainLossOnNonRecourseDebt Gain (Loss) on Non-Recourse Debt USD -719,097 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001193805-15-001351
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001193805-14-000641
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 7.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 10.03M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap Goodwill Goodwill USD 3.53M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap GoodwillGross Goodwill, Gross USD 3.50M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap GrossProfit Gross Profit USD 266.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 182.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 172.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxesPaid Income Taxes Paid USD 30.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 19.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 39.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 17.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 2.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap IncomeTaxReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Amount USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 38.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 2.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 616,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-23 0001193805-16-002889
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 3.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 1.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001140361-24-010147
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 12.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 10.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 13.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD -11.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -7,640 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-12 0001193805-17-000815
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 59.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -33,413 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 19,718 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -934,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -2.76M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 115,041 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 581,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap InterestAndOtherIncome Interest and Other Income USD 3.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap InterestExpense Interest Expense USD 3.77M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001140361-24-025226
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 8.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap InterestExpenseOther Interest Expense, Other USD -8.42M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap InterestExpenseOtherLongTermDebt Interest Expense, Other Long-term Debt USD 1,959 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -9,759 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap InterestIncomeOther Interest Income, Other USD 268,643 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 833,515 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-11 0001193805-17-001446
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 8.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap InterestPayableCurrent Interest Payable, Current USD 123,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 87.78M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap InventoryLIFOReservePeriodCharge Inventory, LIFO Reserve, Period Charge USD 2.10M 2023-04-01 2023-06-30 2023 Q3 10-Q 2023-11-08 0001140361-23-052109
us-gaap InventoryNet Inventory, Net USD 266.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 102.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 76.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap InventoryWriteDown Inventory Write-down USD 2.10M 2023-04-01 2023-06-30 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 300,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 2.70M 2016-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 9.34M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 445,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 510,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.97M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.95M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 633,000 2025-09-30 2025 Q3 10-Q 2025-11-05 0001140361-25-040578
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.39M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap Liabilities Liabilities USD 293.98M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 732.49M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LiabilitiesCurrent Liabilities, Current USD 95.28M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LiabilityPremiumDeficiencyTestingOnLongDurationContractAmount Liability, Premium Deficiency Testing on Long-Duration Contract, Amount USD 344,892 2022-06-30 2022 Q2 10-Q 2022-08-10 0001140361-22-029116
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 35,708 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193805-18-000666
us-gaap LongTermDebt Long-term Debt USD 195.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 4.22M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 4.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 191.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 938,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 191.64M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap LongTermNotesAndLoans Notes and Loans, Noncurrent USD 3.77M 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 93.41M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 1.34M 2016-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 3.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -66.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 105.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 133.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 133.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -5.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap NotesPayable Notes Payable USD 100.00M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 0 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 15.00M 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 14.91M 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OperatingExpenses Operating Expenses USD 88.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 178.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 6.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.18M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 5.77M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 5.88M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 11.84M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 455,444 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.26M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears Operating Leases, Future Minimum Payments, Due in Four and Five Years USD 990,732 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.26M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.39M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.37M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 4.72M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 852,315 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 700,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001193805-21-000411
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.13 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 5.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 768,538 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap OtherCommitment Other Commitment USD 0 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 3.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OtherExpenses Other Expenses USD 200,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap OtherIncome Other Income USD -12,792 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-05 0001193805-20-000960
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193805-18-000666
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap OtherNoncashExpense Other Noncash Expense USD 1,959 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 125,318 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001140361-21-027950
us-gaap OtherNonoperatingGainsLosses Other Nonoperating Gains (Losses) USD 11.53M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -180,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap OtherOperatingIncome Other Operating Income USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap PaymentsForFees Payments for Other Fees USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001193805-21-000411
us-gaap PaymentsForLeasingCosts Payments for Leasing Costs USD 8,360 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD 3.38M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193805-14-002117
us-gaap PaymentsForRent Payments for Rent USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0001140361-22-018668
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 180.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 229,512 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001193805-15-001351
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PaymentsOfDebtRestructuringCosts Payments of Debt Restructuring Costs USD 6.50M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.24M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 119,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 6.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-29 0001193805-18-000470
us-gaap PreferredStockCapitalSharesReservedForFutureIssuance Preferred Stock, Capital Shares Reserved for Future Issuance shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 15.97M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 156,080 2006-06-02 2011-12-31 2012 Q2 10-Q 2012-02-01 0001144204-12-005166
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap ProceedsFromInsuranceSettlementOperatingActivities Proceeds from Insurance Settlement, Operating Activities USD 400,000 2025-01-01 2025-03-18 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 8.87M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap ProceedsFromIssuanceOfMediumTermNotes Proceeds from Issuance of Medium-term Notes USD 20.00M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-03 0001193805-17-003380
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 17.3 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-14 0001193805-12-001369
us-gaap ProceedsFromIssuanceOfSeniorLongTermDebt Proceeds from Issuance of Senior Long-term Debt USD 47.00M 2022-03-23 2022 FY 10-K 2023-03-23 0001140361-23-013467
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 42.94M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001193805-18-001319
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 30.00M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0001140361-25-029177
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap ProceedsFromSaleOfPropertyHeldForSale Proceeds from Sale of Property Held-for-sale USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011030
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001193805-18-001319
us-gaap ProceedsFromSalesOfAssetsInvestingActivities Proceeds from Sales of Assets, Investing Activities USD 504,857 2011-01-01 2011-09-30 2012 Q3 10-Q 2012-11-13 0001193805-12-001795
us-gaap ProceedsFromSecuredNotesPayable Proceeds from Secured Notes Payable USD 16.00M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001193805-15-001351
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 633,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap ProfessionalFees Professional Fees USD 126,200 2006-06-02 2011-12-31 2012 Q2 10-Q 2012-02-01 0001144204-12-005166
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -8.28M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001193805-15-001351
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 110.21M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 66.76M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty Related Party Transaction, Other Revenues from Transactions with Related Party USD 35,708 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-08 0001193805-19-000455
us-gaap RelatedPartyTransactionPurchasesFromRelatedParty Related Party Transaction, Purchases from Related Party USD 160,489 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-08 0001193805-19-000455
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 7,816 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-06 0001193805-20-000562
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 9,395 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001193805-18-001319
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 30.00M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0001140361-25-029177
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 60.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap RepaymentsOfSubordinatedDebt Repayments of Subordinated Debt USD 14.00M 2020-12-08 2021 FY 10-K 2022-03-24 0001140361-22-011030
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 13.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap RestrictedCash Restricted Cash USD 0 2018-09-30 2018 Q3 10-Q 2018-11-09 0001193805-18-001319
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 0 2013-12-31 2013 FY 10-K 2014-03-28 0001193805-14-000641
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 0 2019-09-30 2019 Q3 10-Q 2019-11-06 0001193805-19-001398
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap RestrictedCashEquivalentsCurrent Restricted Cash Equivalents, Current USD 0 2018-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap RestrictedCashEquivalentsNoncurrent Restricted Cash Equivalents, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -28.62M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 379.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-08 0001193805-19-000455
us-gaap RevenueOtherManufacturedProducts Revenue Other Manufactured Products (Deprecated 2018-01-31) USD 4.01M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193805-18-000666
us-gaap Revenues Revenues USD 16.05M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap SalesReturnsGoods Sales Returns, Goods (Deprecated 2018-01-31) USD 5.96M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-11 0001193805-17-001446
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 2.33M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193805-18-000666
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 15.62M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-29 0001193805-18-000470
us-gaap SecurityDeposit Security Deposit USD 44,000 2022-03-31 2022 Q1 10-Q 2022-05-11 0001140361-22-018668
us-gaap SegmentExpenditureAdditionToLongLivedAssets SegmentExpenditureAdditionToLongLivedAssets USD 5.47M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001140361-24-045693
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 80.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap SeniorLongTermNotes Senior Notes, Noncurrent USD 73.40M 2025-06-30 2025 Q2 10-Q 2025-08-06 0001140361-25-029177
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 18.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.69 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.629 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001193805-19-001398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.542 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001193805-19-001398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.026 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-08 0001193805-19-000455
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.017 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-06 0001193805-20-000562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.005 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-06 0001193805-20-000562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares -8,666 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-12 0001193805-16-003725
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 324,425 2015-12-31 2015 FY 10-K 2016-03-23 0001193805-16-002889
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 55.56M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.78M 2020-03-31 2020 Q1 10-Q 2020-05-06 0001193805-20-000562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 4.41 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares -11,598 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares -72,188 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.19M 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-28 0001140361-24-010147
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 39.38M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.94M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 4.45 2020-06-30 2020 Q2 10-Q 2020-08-05 0001193805-20-000960
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 1.04M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001193805-18-001319
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.03 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 4.29 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 3.61 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.96 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001193805-20-001392
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 6.19 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 2.76M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 4.68M 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 3.98 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap ShareRepurchaseProgramExciseTax ShareRepurchaseProgramExciseTax USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap SharesIssued Shares, Issued shares 866,302 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1 2021-10-25 2021 FY 10-K 2022-03-24 0001140361-22-011030
us-gaap ShortTermInvestments Short-term Investments USD 0 2017-12-31 2017 FY 10-K 2018-03-29 0001193805-18-000470
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 438.51M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 373.42M 2025-03-31 2025 Q1 10-Q 2025-05-07 0001140361-25-017747
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 57.50M 2021-10-25 2023 FY 10-K 2024-02-28 0001140361-24-010147
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 0 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-12 0001193805-16-003725
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 6,626 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001193805-21-000411
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 47.17M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001193805-19-000281
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 262,740 2012-01-01 2012-09-30 2013 Q3 10-Q 2013-11-12 0001193805-13-002064
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 64.64M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-18 0001140361-25-009257
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 131.20M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001193805-21-000411
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-24 0001193805-17-000330
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 8,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-13 0001193805-20-000348
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 5.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 55.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap SubordinatedDebt Subordinated Debt USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001193805-21-000411
us-gaap SubordinatedLongTermDebt Subordinated Long-term Debt, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001193805-21-000411
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 624,522 2021-09-30 2021 Q3 10-Q 2021-11-10 0001140361-21-037463
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001140361-24-045693
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 15.60M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 18.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 1.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap TreasuryStockValue Treasury Stock, Value USD 213.74M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 25.28M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-25 0001140361-26-006815
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001140361-24-025226
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -3.90M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0001140361-23-013467
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 229,345 2012-12-31 2012 FY 10-K 2013-03-06 0001193805-13-000585
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 232.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 115.66M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001193805-21-000657
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 229.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001140361-26-041977

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →